AETERNUM HEALTH INC Financials
This page shows AETERNUM HEALTH INC (AETN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue recovery has begun to repair gross economics, but the business still runs under a balance-sheet overhang.
Gross margin flipped from-19.5% to58.9% , showing the latest sales were no longer loss-making at the gross-profit line and that basic transaction economics improved sharply. At the same time, operating cash burn shrank to-$3K even as current liabilities stood at$1.13M , so the operating model improved faster than the financing burden and balance-sheet repair did not follow the same pace.
Even after the gross-profit swing, below-gross costs still dominate: SG&A plus interest were about
The balance sheet is extremely compressed: current ratio fell from 0.6x to 0.05x over the last two annual periods. With cash at
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of AETERNUM HEALTH INC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
AETERNUM HEALTH INC has an operating margin of -132.2%, meaning the company retains $-132 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses.
AETERNUM HEALTH INC's revenue surged 212.7% year-over-year to $204K, reflecting rapid business expansion. This strong growth earns a score of 100/100.
AETERNUM HEALTH INC's current ratio of 0.05 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.
AETERNUM HEALTH INC passes 3 of 9 financial strength tests. 1 of 3 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, AETERNUM HEALTH INC generates $0.01 in operating cash flow (-$3K OCF vs -$337K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
AETERNUM HEALTH INC earns $-4.0 in operating income for every $1 of interest expense (-$269K vs $68K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
AETERNUM HEALTH INC generated $204K in revenue in fiscal year 2025. This represents an increase of 212.7% from the prior year.
AETERNUM HEALTH INC reported -$337K in net income in fiscal year 2025.
AETERNUM HEALTH INC earned $-0.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Cash & Balance Sheet
AETERNUM HEALTH INC held $0 in cash against $0 in long-term debt as of fiscal year 2025.
AETERNUM HEALTH INC had 49M shares outstanding in fiscal year 2025. This represents an increase of 1.5% from the prior year.
Margins & Returns
AETERNUM HEALTH INC's gross margin was 59.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 78.5 percentage points from the prior year.
AETERNUM HEALTH INC's operating margin was -132.2% in fiscal year 2025, reflecting core business profitability.
AETERNUM HEALTH INC's net profit margin was -165.5% in fiscal year 2025, showing the share of revenue converted to profit.
Capital Allocation
AETN Income Statement
| Metric | Q2'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2K-90.4% | $24K+182.0% | $8K+17.2% | $7K-95.7% | $165K+1219.4% | $12K-19.2% | $15K-53.7% | $33K |
| Cost of Revenue | $13K | N/A | N/A | N/A | N/A | N/A | $29K+31.0% | $22K |
| Gross Profit | -$12K-233.7% | $9K+204.0% | -$9K-52.7% | -$6K-104.5% | $125K+682.3% | -$22K-44.6% | -$15K-145.8% | $33K |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $37K+37.9% | $27K-28.2% | $38K+154.1% | $15K-42.3% | $26K-19.5% | $32K+165.0% | $12K-64.8% | $34K |
| Operating Income | -$120K-45.2% | -$82K+31.9% | -$121K-36.3% | -$89K-490.2% | $23K | N/A | -$110K-18.8% | -$93K |
| Interest Expense | $20K+18.9% | $17K0.0% | $17K-1.3% | $17K+1.8% | $17K-0.4% | $17K-1.1% | $17K-27.7% | $24K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$140K-40.7% | -$99K+28.0% | -$138K-30.2% | -$106K-1896.9% | $6K | N/A | -$77K+33.6% | -$116K |
| EPS (Diluted) | $0.00 | N/A | $0.00 | $0.00 | $0.00 | N/A | $0.00 | $0.00 |
AETN Balance Sheet
| Metric | Q2'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $75K+37.5% | $55K-26.3% | $74K-48.9% | $145K-20.1% | $182K+177.5% | $65K-10.4% | $73K-19.6% | $91K |
| Current Assets | $59K+10.2% | $54K-26.7% | $73K-49.3% | $144K-20.2% | $181K+180.2% | $64K-10.6% | $72K-19.8% | $90K |
| Cash & Equivalents | $19K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $39K+4.8% | $37K+102.9% | $18K-3.6% | $19K0.0% | $19K-57.5% | $45K+29.5% | $35K+89.6% | $18K |
| Accounts Receivable | $866-12.0% | $984+16.7% | $843-99.2% | $102K-37.0% | $162K | $0-100.0% | $15K+2.9% | $14K |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $2.1M+4.1% | $2.1M+4.0% | $2.0M+3.5% | $1.9M+3.8% | $1.8M+5.5% | $1.7M+8.2% | $1.6M+3.8% | $1.6M |
| Current Liabilities | $1.2M+7.4% | $1.1M+7.6% | $1.1M+6.8% | $987K+7.6% | $918K+11.7% | $822K+19.1% | $690K+13.7% | $607K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$2.1M-3.2% | -$2.0M-5.2% | -$1.9M-7.8% | -$1.8M-6.4% | -$1.7M+1.2% | -$1.7M-9.1% | -$1.5M-5.3% | -$1.5M |
| Retained Earnings | -$3.4M-4.3% | -$3.3M-3.1% | -$3.2M-4.5% | -$3.0M-3.6% | -$2.9M+0.2% | -$2.9M-5.0% | -$2.8M-2.8% | -$2.7M |
AETN Cash Flow Statement
| Metric | Q2'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$56K-46.0% | -$39K-208.1% | $36K+95.1% | $18K+199.6% | -$18K-1649.2% | -$1K+86.9% | -$8K+89.2% | -$74K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $60K | N/A | N/A | N/A | N/A | -$1+100.0% | -$24K+53.8% | -$52K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
AETN Financial Ratios
| Metric | Q2'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -530.0%-568.0pp | 38.1%+141.3pp | -103.3%-24.0pp | -79.2%-155.4pp | 76.1%+248.6pp | -172.5%-76.1pp | -96.4%-193.8pp | 97.5% |
| Operating Margin | -5289.8%-4939.8pp | -350.0%+1099.3pp | -1449.3%-203.7pp | -1245.6%-1259.4pp | 13.8% | N/A | -712.9%-435.2pp | -277.6% |
| Net Margin | -6179.4%-5757.6pp | -421.9%+1230.1pp | -1652.0%-165.7pp | -1486.3%-1489.9pp | 3.6% | N/A | -499.9%-151.3pp | -348.6% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -186.2%-4.2pp | -182.0%+4.2pp | -186.2%-113.1pp | -73.0%-76.3pp | 3.3% | N/A | -105.7%+22.3pp | -128.0% |
| Current Ratio | 0.050.0 | 0.05-0.0 | 0.07-0.1 | 0.15-0.1 | 0.20+0.1 | 0.08-0.0 | 0.10-0.0 | 0.15 |
| Debt-to-Equity | -1.040.0 | -1.03+0.0 | -1.04+0.0 | -1.08+0.0 | -1.11-0.1 | -1.040.0 | -1.05+0.0 | -1.06 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$2.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.05), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Frequently Asked Questions
What is AETERNUM HEALTH INC's annual revenue?
AETERNUM HEALTH INC (AETN) reported $204K in total revenue for fiscal year 2025. This represents a 212.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is AETERNUM HEALTH INC's revenue growing?
AETERNUM HEALTH INC (AETN) revenue grew by 212.7% year-over-year, from $65K to $204K in fiscal year 2025.
Is AETERNUM HEALTH INC profitable?
No, AETERNUM HEALTH INC (AETN) reported a net income of -$337K in fiscal year 2025, with a net profit margin of -165.5%.
What is AETERNUM HEALTH INC's gross margin?
AETERNUM HEALTH INC (AETN) had a gross margin of 59.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is AETERNUM HEALTH INC's operating margin?
AETERNUM HEALTH INC (AETN) had an operating margin of -132.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is AETERNUM HEALTH INC's net profit margin?
AETERNUM HEALTH INC (AETN) had a net profit margin of -165.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is AETERNUM HEALTH INC's operating cash flow?
AETERNUM HEALTH INC (AETN) generated -$3K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are AETERNUM HEALTH INC's total assets?
AETERNUM HEALTH INC (AETN) had $55K in total assets as of fiscal year 2025, including both current and long-term assets.
What is AETERNUM HEALTH INC's current ratio?
AETERNUM HEALTH INC (AETN) had a current ratio of 0.05 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is AETERNUM HEALTH INC's debt-to-equity ratio?
AETERNUM HEALTH INC (AETN) had a debt-to-equity ratio of -1.03 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is AETERNUM HEALTH INC's return on assets (ROA)?
AETERNUM HEALTH INC (AETN) had a return on assets of -617.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is AETERNUM HEALTH INC's cash runway?
Based on fiscal year 2025 data, AETERNUM HEALTH INC (AETN) had $0 in cash against an annual operating cash burn of $3K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is AETERNUM HEALTH INC's debt-to-equity ratio negative or unusual?
AETERNUM HEALTH INC (AETN) has negative shareholder equity of -$2.0M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is AETERNUM HEALTH INC's Piotroski F-Score?
AETERNUM HEALTH INC (AETN) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are AETERNUM HEALTH INC's earnings high quality?
AETERNUM HEALTH INC (AETN) has an earnings quality ratio of 0.01x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can AETERNUM HEALTH INC cover its interest payments?
AETERNUM HEALTH INC (AETN) has an interest coverage ratio of -4.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is AETERNUM HEALTH INC?
AETERNUM HEALTH INC (AETN) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.